Cargando…

Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma

Glioblastoma (GBM) is a hypervascular neoplasia of the central nervous system with an extremely high rate of mortality. Owing to its hypervascularity, anti-angiogenic therapies (AAT) have been used as an adjuvant to the traditional surgical resection, chemotherapy, and radiation. The benefits of AAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angara, Kartik, Borin, Thaiz F., Arbab, Ali S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496207/ https://www.ncbi.nlm.nih.gov/pubmed/28668763 http://dx.doi.org/10.1016/j.tranon.2017.04.007

Ejemplares similares

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018)

Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
por: Arbab, Ali S., et al.
Publicado: (2017)

Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
por: Borin, Thaiz F., et al.
Publicado: (2017)

Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study
por: Ali, Sehar, et al.
Publicado: (2021)

Vascular Mimicry: The Next Big Glioblastoma Target
por: Arbab, Ali S, et al.
Publicado: (2015)

ANGI-05 PATHOGENESIS OF RESISTANCE (MIMICRY AND CO-OPTION) TO ANTI-ANGIOGENIC TREATMENT FOR GLIOBLASTOMA
por: Takano, Shingo, et al.
Publicado: (2019)

Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
por: Achyut, B. R., et al.
Publicado: (2017)

HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model
por: Borin, Thaiz F., et al.
Publicado: (2017)

Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)

Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models
por: Jain, Meenu, et al.
Publicado: (2017)

Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma
por: Ali, Meser M., et al.
Publicado: (2010)

Thoracic Articles in AATS Journals
Publicado: (2022)

Evaluation of the anti-angiogenic action of melatonin in breast cancer
por: Jardim, Bruna V, et al.
Publicado: (2013)

The Anti-angiogenic Effect of Chlorogenic Acid on Choroidal Neovascularization
por: Kim, Cinoo, et al.
Publicado: (2010)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
por: Jeon, Hanwool, et al.
Publicado: (2023)

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice
por: Borin, Thaiz Ferraz, et al.
Publicado: (2014)

Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo
por: Janosz, Ewa, et al.
Publicado: (2021)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
por: Onishi, Manabu, et al.
Publicado: (2013)

An Angiogenic Role for Adrenomedullin in Choroidal Neovascularization
por: Sakimoto, Susumu, et al.
Publicado: (2013)

Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases
por: Vavilala, Divya Teja, et al.
Publicado: (2014)

Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
por: Conroy, Siobhan, et al.
Publicado: (2016)

Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma
por: Varma, Nadimpalli Ravi S, et al.
Publicado: (2013)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry
por: Baisiwala, Shivani, et al.
Publicado: (2019)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019)

Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy
por: Kwiatkowski, Sam C., et al.
Publicado: (2017)

NRFL-1, the C. elegans NHERF Orthologue, Interacts with Amino Acid Transporter 6 (AAT-6) for Age-Dependent Maintenance of AAT-6 on the Membrane
por: Hagiwara, Kohei, et al.
Publicado: (2012)

Differences between Female and Male Inmates in Animal Assisted Therapy (AAT) in Austria: Do We Need Treatment Programs Specific to the Needs of Females in AAT?
por: Stetina, Birgit U., et al.
Publicado: (2020)

Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets
por: Mao, Jin-ming, et al.
Publicado: (2015)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
por: Wang, Jing, et al.
Publicado: (2021)

Complete Genome Sequence of Pseudomonas aeruginosa Phage AAT-1
por: Andrade-Domínguez, Andrés, et al.
Publicado: (2016)

Seminars AATS International Roundtable of Lung Transplantation for COVID-19
por: Ripley, R. Taylor, et al.
Publicado: (2022)

Sustained miRNA-mediated Knockdown of Mutant AAT With Simultaneous Augmentation of Wild-type AAT Has Minimal Effect on Global Liver miRNA Profiles
por: Mueller, Christian, et al.
Publicado: (2012)

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
por: Verhoeff, Joost JC, et al.
Publicado: (2009)

Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
por: Zhang, Ashley B., et al.
Publicado: (2023)

Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1
por: Amambua-Ngwa, Alfred, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pbe58pmiadmu8gv3fokf11d1bf